<?xml version="1.0" encoding="UTF-8"?>
<wcm:root xmlns:wcm="http://www.stellent.com/wcm-data/ns/8.0.0">
  <wcm:element name="MainContent">&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;DEPARTMENT OF HEALTH AND HUMAN SERVICES&lt;/p&gt;&lt;div style="text-align: left"&gt;Food and Drug Administration&lt;/div&gt;&lt;div style="text-align: left"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="text-align: left"&gt;[Docket No. &lt;a name="Text14"&gt;FDA-2011-N-0002&lt;/a&gt;]&lt;/div&gt;&lt;div style="text-align: left"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="text-align: left"&gt;Microbiology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting&lt;/div&gt;&lt;div style="text-align: left"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="text-align: left"&gt;AGENCY:&amp;nbsp;Food and Drug Administration, HHS.&lt;/div&gt;&lt;div style="text-align: left"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="text-align: left"&gt;ACTION:&amp;nbsp;Notice.&lt;/div&gt;&lt;div style="text-align: left"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="text-align: left"&gt;This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA).&amp;nbsp;The meeting will be open to the public.&lt;/div&gt;&lt;div style="text-align: left"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="text-align: left"&gt;&lt;u&gt;Name of Committee&lt;/u&gt;: Microbiology Devices Panel of the Medical Devices Advisory Committee.&lt;/div&gt;&lt;div style="text-align: left"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="text-align: left"&gt;&lt;u&gt;General Function of the Committee&lt;/u&gt;:&amp;nbsp;To provide advice and recommendations to the Agency on FDA's regulatory issues.&lt;/div&gt;&lt;div style="text-align: left"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="text-align: left"&gt;&lt;u&gt;Date and Time&lt;/u&gt;:&amp;nbsp;The meeting will be held on June 29, 2011, from 8 a.m. to 6 p.m.&lt;/div&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="text-align: left"&gt;&lt;u&gt;Location&lt;/u&gt;: Holiday Inn, Ballroom, 2 Montgomery Village Ave., Gaithersburg, MD&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;u&gt;Contact Person&lt;/u&gt;: Shanika Craig, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 1613&lt;span&gt;, &lt;/span&gt;Silver Spring MD 20993-0002, 301-796-6639, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), and follow the prompts to the desired center or product area.&amp;nbsp;Please call the Information Line for up-to-date information on this meeting.&amp;nbsp;A notice in the &lt;u&gt;Federal Register&lt;/u&gt; about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice.&amp;nbsp;Therefore, you should always check the Agency's Web site and call the appropriate advisory committee hot line/phone line to learn about possible modifications before coming to the meeting.&lt;/p&gt;&lt;div style="text-align: left"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="text-align: left"&gt;&lt;u&gt;Agenda&lt;/u&gt;:&amp;nbsp;On June 29, 2011, the committee will discuss and make recommendations regarding &lt;span&gt;the possible reclassification of molecular diagnostics for the rapid detection of &lt;u&gt;&lt;span&gt;Mycobacterium tuberculosis &lt;/span&gt;&lt;/u&gt;complex and the detection of genetic mutations which confer antibiotic resistance in &lt;u&gt;M. tuberculosis &lt;/u&gt;complex. Discussion would include the appropriate information and acceptable performance characteristics that would be required to assess the safety and effectiveness of rapid diagnostic tests for &lt;u&gt;M. tuberculosis&lt;/u&gt; complex, and whether these can be sufficiently specified to support possible reclassification. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align: left"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="text-align: left"&gt;FDA intends to &lt;span id="1300270780159E" style="display: none"&gt;&amp;nbsp;&lt;/span&gt;make background material available to the public no later than 2 business days before the meeting.&amp;nbsp;If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA's Web site after the meeting.&amp;nbsp;Background material is available at &lt;a href="http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm"&gt;&lt;font color="#800080"&gt;http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm&lt;/font&gt;&lt;/a&gt;. Scroll down to the appropriate advisory committee link.&lt;/div&gt;&lt;div style="text-align: left"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="text-align: left"&gt;&lt;u&gt;Procedure&lt;/u&gt;:&amp;nbsp;Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee.&amp;nbsp;Written submissions may be made to the contact person on or before June 20, 2011.&amp;nbsp;Oral presentations from the public will be scheduled between approximately 10:30 a.m. and 11:30 a.m. on June 29, 2011.&amp;nbsp;Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before June 9, 2011.&amp;nbsp;Time allotted for each presentation may be limited.&amp;nbsp;If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session.&amp;nbsp;The contact person will notify interested persons regarding their request to speak by June 10, 2011.&lt;/div&gt;&lt;div style="text-align: left"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="text-align: left"&gt;Persons attending FDA's advisory committee meetings are advised that the Agency is not responsible for providing access to electrical outlets.&lt;/div&gt;&lt;div style="text-align: left"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="text-align: left"&gt;FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact AnnMarie Williams, Committee Management Staff, 301-796-5966, at least 7 days in advance of the meeting.&lt;/div&gt;&lt;div style="text-align: left"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="text-align: left"&gt;FDA is committed to the orderly conduct of its advisory committee meetings.&amp;nbsp;Please visit our Web site at &lt;a href="http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm"&gt;http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm&lt;/a&gt; for procedures on public conduct during advisory committee meetings.&lt;/div&gt;&lt;div style="text-align: left"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="text-align: left"&gt;Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2).&lt;/div&gt;&lt;div style="text-align: left"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="text-align: left"&gt;Dated: &lt;u&gt;March 11, 2011&lt;/u&gt;.&lt;/div&gt;&lt;div style="text-align: left"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="text-align: left"&gt;Leslie Kux,&lt;/div&gt;&lt;div style="text-align: left"&gt;Acting Assistant Commissioner for Policy.&lt;span id="1300270455249E" style="display: none"&gt;&amp;nbsp;&lt;span id="1300270473467E" style="display: none"&gt;&amp;nbsp;&lt;span id="1300270525362E" style="display: none"&gt;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;p style="text-align: left"&gt;&lt;span id="1300270636410E" style="display: none"&gt;&amp;nbsp;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;span id="1300270594965E" style="display: none"&gt;&amp;nbsp;&lt;/span&gt;&lt;span id="1300270580238E" style="display: none"&gt;&amp;nbsp;&lt;/span&gt;&lt;/p&gt;</wcm:element>
</wcm:root>
